JP2024543497A5 - - Google Patents
Info
- Publication number
- JP2024543497A5 JP2024543497A5 JP2024528586A JP2024528586A JP2024543497A5 JP 2024543497 A5 JP2024543497 A5 JP 2024543497A5 JP 2024528586 A JP2024528586 A JP 2024528586A JP 2024528586 A JP2024528586 A JP 2024528586A JP 2024543497 A5 JP2024543497 A5 JP 2024543497A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- heterocycloalkyl
- cycloalkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/130284 | 2021-11-12 | ||
| CN2021130284 | 2021-11-12 | ||
| CN2022123821 | 2022-10-08 | ||
| CNPCT/CN2022/123821 | 2022-10-08 | ||
| PCT/CN2022/131290 WO2023083285A1 (en) | 2021-11-12 | 2022-11-11 | Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543497A JP2024543497A (ja) | 2024-11-21 |
| JP2024543497A5 true JP2024543497A5 (https=) | 2025-11-19 |
Family
ID=86335132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024528586A Pending JP2024543497A (ja) | 2021-11-12 | 2022-11-11 | ユビキチン特異的プロテアーゼ１（ｕｓｐ１）の小分子阻害剤及びその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20250066348A1 (https=) |
| EP (1) | EP4430049A4 (https=) |
| JP (1) | JP2024543497A (https=) |
| KR (1) | KR20240117555A (https=) |
| CN (1) | CN119173515A (https=) |
| AU (1) | AU2022387669A1 (https=) |
| CA (1) | CA3235603A1 (https=) |
| CL (1) | CL2024001398A1 (https=) |
| CO (1) | CO2024006278A2 (https=) |
| CR (1) | CR20240190A (https=) |
| DO (1) | DOP2024000081A (https=) |
| GE (1) | GEAP202416531A (https=) |
| IL (1) | IL312640A (https=) |
| JO (1) | JOP20240095A1 (https=) |
| MX (1) | MX2024005756A (https=) |
| PE (1) | PE20241350A1 (https=) |
| WO (1) | WO2023083285A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL312642A (en) | 2021-11-12 | 2024-07-01 | Insilico Medicine Ip Ltd | Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof |
| WO2023155866A1 (zh) * | 2022-02-18 | 2023-08-24 | 四川海思科制药有限公司 | 一种吡唑并吡啶衍生物及其在医药上的应用 |
| WO2024022266A1 (en) * | 2022-07-25 | 2024-02-01 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Heteroaryl compounds as inhibitors of usp1 |
| WO2024032647A1 (zh) * | 2022-08-09 | 2024-02-15 | 上海济煜医药科技有限公司 | 含氮杂环化合物作为泛素-特异性蛋白酶1抑制剂的制备方法、应用及其用途 |
| JP2025531133A (ja) * | 2022-09-20 | 2025-09-19 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | ユビキチン特異的プロテアーゼ阻害剤としてのカルボニル縮合複素環誘導体 |
| CN120603835A (zh) * | 2023-01-20 | 2025-09-05 | 杭州英创医药科技有限公司 | 作为usp1抑制剂的化合物 |
| KR20260033560A (ko) * | 2023-07-05 | 2026-03-10 | 장슈 야홍 메디텍 코퍼레이션 리미티드 | 피리미딘 화합물, 이의 제조 방법 및 이의 의학적 용도 |
| WO2025010245A1 (en) | 2023-07-06 | 2025-01-09 | Exelixis, Inc. | Fused pyrazole derivatives as usp1 inhibitors |
| WO2025015905A1 (en) * | 2023-07-14 | 2025-01-23 | Laekna Therapeutics Shanghai Co., Ltd. | Pyrimidine compounds and their use as usp1 inhibitors |
| TW202530200A (zh) * | 2023-09-25 | 2025-08-01 | 大陸商上海濟煜醫藥科技有限公司 | 嗒𠯤酮類化合物作為泛素－特異性蛋白酶１抑制劑的製備方法、應用及其用途 |
| TW202530229A (zh) * | 2023-09-26 | 2025-08-01 | 大陸商上海濟煜醫藥科技有限公司 | 氮雜環胺類化合物作為泛素-特異性蛋白酶１抑制劑的製備方法、應用及其用途 |
| WO2025102016A1 (en) | 2023-11-10 | 2025-05-15 | Vrise Therapeutics, Inc. | Novel molecules as inhibitors of dna damage repair pathway |
| TW202539659A (zh) | 2024-01-10 | 2025-10-16 | 美商維瑞斯治療股份有限公司 | Ｄｎａ損傷修復途徑的新穎抑制劑 |
| WO2025227060A1 (en) * | 2024-04-26 | 2025-10-30 | Insilico Medicine Ip Limited | Heterocyclic inhibitors of ubiquitin specific protease 1 (usp1) in combination with additional agents for use in the treatment of cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108473495B (zh) * | 2015-11-20 | 2022-04-12 | 福马治疗有限公司 | 作为泛素-特异性蛋白酶1抑制剂的嘌呤酮 |
| US11485736B2 (en) * | 2018-12-20 | 2022-11-01 | KSQ Therapeutics, Inc. | Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors |
| WO2021163530A1 (en) * | 2020-02-14 | 2021-08-19 | KSQ Therapeutics, Inc. | Therapeutic combinations comprising ubiquitin-specific-processing protease 1 (usp1) inhibitors and poly (adp-ribose) polymerase (parp) inhibitors |
| KR20230098186A (ko) * | 2020-10-30 | 2023-07-03 | 케이에스큐 세러퓨틱스 인코포레이티드 | 치환된 피라졸로피리미딘의 고체 상태 형태 및 이의 용도 |
| EP4291559A1 (en) * | 2021-02-15 | 2023-12-20 | Tango Therapeutics, Inc. | Pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer |
| WO2022197892A1 (en) * | 2021-03-17 | 2022-09-22 | Tango Therapeutics, Inc. | Purine derivatives as anticancer agents |
| WO2022199652A1 (en) * | 2021-03-24 | 2022-09-29 | Impact Therapeutics (Shanghai) , Inc | Five-membered heteroaryl-pyrimidine compounds as usp1 inhibitors and the use thereof |
| CA3214040A1 (en) * | 2021-04-07 | 2022-10-13 | Forma Therapeutics, Inc. | Inhibiting ubiquitin-specific protease 1 (usp1) |
-
2022
- 2022-11-11 EP EP22892078.1A patent/EP4430049A4/en active Pending
- 2022-11-11 IL IL312640A patent/IL312640A/en unknown
- 2022-11-11 CA CA3235603A patent/CA3235603A1/en active Pending
- 2022-11-11 JP JP2024528586A patent/JP2024543497A/ja active Pending
- 2022-11-11 US US18/708,686 patent/US20250066348A1/en active Pending
- 2022-11-11 WO PCT/CN2022/131290 patent/WO2023083285A1/en not_active Ceased
- 2022-11-11 AU AU2022387669A patent/AU2022387669A1/en active Pending
- 2022-11-11 MX MX2024005756A patent/MX2024005756A/es unknown
- 2022-11-11 CN CN202280087722.8A patent/CN119173515A/zh active Pending
- 2022-11-11 GE GEAP202416531A patent/GEAP202416531A/en unknown
- 2022-11-11 CR CR20240190A patent/CR20240190A/es unknown
- 2022-11-11 PE PE2024001034A patent/PE20241350A1/es unknown
- 2022-11-11 KR KR1020247018880A patent/KR20240117555A/ko active Pending
-
2024
- 2024-04-24 JO JOJO/P/2024/0095A patent/JOP20240095A1/ar unknown
- 2024-05-09 CL CL2024001398A patent/CL2024001398A1/es unknown
- 2024-05-10 DO DO2024000081A patent/DOP2024000081A/es unknown
- 2024-05-17 CO CONC2024/0006278A patent/CO2024006278A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024543497A5 (https=) | ||
| JP2024543475A5 (https=) | ||
| JP2024543477A5 (https=) | ||
| JP2017523972A5 (https=) | ||
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| RU2501791C2 (ru) | Производное триазола или его соль | |
| JP2022534426A5 (https=) | ||
| HK1245780A1 (en) | Imidazopyrrolidinone compounds | |
| JP2020507582A5 (https=) | ||
| WO2015015318A4 (en) | Novel quinazolinones as bromodomain inhibitors | |
| JP2021535112A5 (https=) | ||
| EP2855483A1 (en) | Pyrrolopyrrolidinone compounds | |
| JP2012508252A5 (https=) | ||
| JP2009538897A5 (https=) | ||
| JP2016525078A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2021521104A5 (https=) | ||
| JP2011526917A5 (https=) | ||
| JP2014500322A5 (https=) | ||
| JP2013532652A5 (https=) | ||
| JP2022549222A5 (https=) | ||
| JP2010527984A5 (https=) | ||
| HRP20231571T1 (hr) | Derivati fenil/piridil-nh-fenil/piridil za liječenje infekcija rna virusom | |
| JP2020520893A5 (https=) | ||
| CN101420950A (zh) | 杜兴肌营养不良的治疗 |